Cardlytics, Inc. (CDLX) Stock

About Cardlytics, Inc.

Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments. This system allows marketers to engage customers through the vast networks of their financial institution partners, leveraging digital avenues such as online portals, mobile applications, email, and various real-time alerts. Furthermore, the company offers the Bridg platform, a comprehensive customer data solution that processes point-of-sale information. This enables marketers to conduct advanced analytics, implement highly targeted loyalty initiatives, and precisely evaluate the performance of their marketing efforts. Cardlytics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.

Cardlytics, Inc. is led by CEO Amit Gupta, employs 440 people, headquartered in US, publicly traded since 2018.

Cardlytics, Inc. (CDLX) stock trades at $1.80 with a market capitalization of $10.60M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.12, reflecting a net loss over the last twelve months, a negative price-to-book of -0.82, reflecting negative shareholders' equity, price-to-sales of 0.07. Over the past 52 weeks the stock has ranged between $1.67 and $21.70, and currently trades 91.7% below its 52-week high.

On profitability, Cardlytics, Inc. generates a return on equity (ROE) of -870.86% (not meaningful, as shareholders' equity is negative), return on capital employed of -22.60%, an operating margin of -20.17%, a net profit margin of -55.92%.

Official website: www.cardlytics.com

Cardlytics, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Cardlytics, Inc. reported revenue of $113.0M rising to $233.0M, a change of +106.2% across 10 years. Compounded, revenue has grown 4.5% a year over five years, -8.0% over three, -16.2% over the last twelve months. Net profit fell to $-103.0M.

Operating margin went from -49.8% in 2016 to -20.2% in 2025, a gain of 29.6 percentage points. The most recent net margin is -55.92%. On a trailing twelve-month basis to Jun '26, revenue is $179.0M and net profit $-100.0M.

Borrowings rose from $112.0M to $215.0M, cash from operations was $9.0M in the latest year, positive in 2 of the last 10.

Return on equity has averaged 172.7% over five years, and was 1471.4% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Cardlytics, Inc. (CDLX) — frequently asked questions